Skip to main content
. 2016 Jul 26;7(44):72276–72289. doi: 10.18632/oncotarget.10848

Table 2. Prognostic factors for DFS and OS by univariate analysis.

Variables n DFS P OS P
1-yr 3-yrs 5-yrs 1-yr 3-yrs 5-yrs
Gender
Male 271 43.2% 29.9% 26.0% 0.154 70.1% 44.6% 36.8% 0.032
Female 32 56.3% 37.5% 37.5% 81.3% 59.4% 56.3%
Age(yrs)
<60 230 43.9% 32.2% 29.5% 0.457 70.9% 47.4% 39.9% 0.430
≥60 73 46.6% 26.0% 20.0% 72.6% 42.5% 35.5%
HBsAg
 Positive 266 41.4% 28.9% 25.0% 0.02 69.2% 44.4% 37.5% 0.075
 Negative 37 67.6% 43.2% 43.2% 86.5% 59.5% 48.6%
AFP(μg/L)
< 200 132 54.5% 38.6% 36.3% < 0.001 78.8% 53.0% 46.2% 0.006
≥200 171 36.8% 24.6% 20.3% 65.5% 40.9% 33.2%
Hb(g/L)
 ≤120 48 31.2% 16.7% 16.7% 0.052 68.7% 33.3% 29.2% 0.222
 >120 255 47.1% 34.1% 29.2% 71.8% 48.6% 40.7%
WBC(×109)
 < 10 271 45.4% 31.4% 27.5% 0.588 72.3% 46.1% 39.0% 0.977
 ≥ 10 32 37.5% 25.0% 25.0% 62.5% 46.9% 37.5%
AST(U/L)
 < 80 150 57.3% 41.3% 37.8% < 0.001 83.3% 58.7% 50.6% < 0.001
 ≥ 80 153 32.0% 20.3% 16.9% 59.5% 34.0% 27.4%
Neutrophil(×109)
 < 3.94 168 49.4% 35.1% 30.8% 0.018 78.6% 51.2% 44.0% 0.032
 ≥ 3.94 135 38.5% 25.2% 22.8% 62.2% 40.0% 32.6%
CLIP score
 0-2 217 55.3% 39.2% 34.4% < 0.001 80.6% 56.2% 48.8% < 0.001
 3-5 86 17.4% 9.3% 9.3% 47.7% 20.9% 13.4%
TNM
I 175 52.0% 36.6% 32.4% 0.001 77.7% 54.3% 47.3% < 0.001
II-III 128 34.4% 22.7% 20.1% 62.5% 35.2% 27.3%
Cirrhosis
No 66 40.9% 27.3% 24.2% 0.454 75.8% 45.5% 37.9% 0.803
Yes 237 45.6% 31.6% 28.1% 70.0% 46.4% 39.2%

HBsAg: hepatitis B surface antigen; AFP:alpha-fetoprotein; Hb: hemoglobin; WBC: white blood cell; AST: aspartate aminotransferase ratio index; CLIP: cancer of the liver Italian program; TNM: Tumor Node Metastasis.